About luye pharma group - LYPHF
Luye Pharma Group Ltd. is an investment holding company, which engages in the developing, producing, marketing, and selling of pharmaceutical products. It operates through the following segments: Oncology Drugs, Cardiovascular System Drugs, Alimentary Tract and Metabolism Drugs, and Others. The company was founded on June 8, 1994 and is headquartered in Yantai, China.
LYPHF At a Glance
Luye Pharma Group Ltd.
No. 15 Chuang Ye Road
Yantai, Shandong 264003
| Phone | 86-535-671-7618 | Revenue | 842.24M | |
| Industry | Pharmaceuticals: Major | Net Income | 65.57M | |
| Sector | Health Technology | Employees | 5,150 | |
| Fiscal Year-end | 12 / 2025 | |||
| View SEC Filings |
LYPHF Valuation
| P/E Current | 15.402 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 16.055 |
| Price to Sales Ratio | 1.248 |
| Price to Book Ratio | 0.542 |
| Price to Cash Flow Ratio | 53.495 |
| Enterprise Value to EBITDA | 6.042 |
| Enterprise Value to Sales | 1.938 |
| Total Debt to Enterprise Value | 0.866 |
LYPHF Efficiency
| Revenue/Employee | 163,541.569 |
| Income Per Employee | 12,731.787 |
| Receivables Turnover | 1.404 |
| Total Asset Turnover | 0.22 |
LYPHF Liquidity
| Current Ratio | 1.236 |
| Quick Ratio | 1.151 |
| Cash Ratio | 0.713 |
LYPHF Profitability
| Gross Margin | 66.60 |
| Operating Margin | 19.029 |
| Pretax Margin | 13.858 |
| Net Margin | 7.785 |
| Return on Assets | 1.714 |
| Return on Equity | 3.538 |
| Return on Total Capital | 1.955 |
| Return on Invested Capital | 2.891 |
LYPHF Capital Structure
| Total Debt to Total Equity | 72.917 |
| Total Debt to Total Capital | 42.169 |
| Total Debt to Total Assets | 34.854 |
| Long-Term Debt to Equity | 19.329 |
| Long-Term Debt to Total Capital | 11.178 |